Our news library that includes all press releases and industry related news.
Press Release June 12, 2025
Geneva and Ottawa, June 12 – Ahead of the upcoming G7 Leaders’ Summit, the global pharmaceutical industry, represented by the […]
In the news June 12, 2025
Dear G7 Governments, On behalf of the innovative pharmaceutical industry we represent, we would like to convey ahead of the […]
Statements May 27, 2025
Ottawa, May 27, 2025 – Today, His Majesty King Charles III delivered the Speech from the Throne, outlining the federal […]
Statements May 26, 2025
Ottawa, May 26, 2025 – Innovative Medicines Canada welcomes the launch of CanReview, a pan-Canadian initiative supported by the Accelerating […]
In the news May 14, 2025
Ensuring Pharmacare delivers fair access for all and innovation As originally published in The Hill Times Policy Briefing on May […]
Press Release May 12, 2025
Innovative Pharmaceutical Industry Contributed $18.4 Billion to the Canadian Economy in 2022 Ottawa, May 12, 2024 – New data released […]
Press Release May 05, 2025
Nominate Trailblazers in Health Equity Ottawa, May 5, 2025 – The Health Research Foundation (HRF) of Innovative Medicines Canada is […]
Press Release April 29, 2025
Ottawa, ON – Innovative Medicines Canada (IMC) congratulates Mark Carney on his election as Canada’s Prime Minister, the Liberal Party […]
Press Release April 23, 2025
NOMINATE OUTSTANDING CONTRIBUTIONS TO HEALTH SCIENCES, POLICY, AND RESEARCH BY JULY 15, 2025 Ottawa, April 23 – The Health Research […]
Press Release April 01, 2025
Ottawa, April 1, 2025 – Quebec signed a bilateral agreement under the federal government’s National Strategy for Drugs for Rare […]
Statements March 27, 2025
Industry Association Applauds Commitment to the Stratégie Québécoise des sciences de la vie (2025-2028) and to Pharmaceuticals in Hospital Settings […]
March 21, 2025
Ottawa, le 21 mars 2025. – Avec l’annonce imminente d’élections fédérales, les Canadiens ont l’occasion de réfléchir à l’avenir de leur système de […]
Informative content to keep you up to date on the most pressing issues facing our industry.
